Alterity Therapeutics : Enrols First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy - Form 6-K
Alterity Therapeutics Enrols First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA - 4... | April 4, 2023